{
  "expert_panel": {
    "description": "Multi-disciplinary expert panel for irAKI classification",
    "version": "1.0",
    "experts": [
      {
        "id": "oncologist",
        "specialty": "medical_oncology",
        "name": "Dr. Sarah Chen",
        "experience_years": 15,
        "credentials": "MD, PhD, FACP",
        "institution": "Comprehensive Cancer Center",
        "expertise": [
          "immune checkpoint inhibitor toxicities",
          "immune-related adverse events (irAEs)",
          "cancer immunotherapy",
          "oncology supportive care",
          "immunotherapy combinations"
        ],
        "focus_areas": [
          "temporal relationship between immunotherapy and AKI",
          "other irAE assessment and correlation",
          "immunotherapy dosing and scheduling effects",
          "rechallenge considerations after irAKI"
        ],
        "clinical_experience": "Managed >2000 patients on immune checkpoint inhibitors, published 50+ papers on irAEs",
        "reasoning_style": "evidence-based, protocol-driven, considers long-term cancer outcomes"
      },
      {
        "id": "nephrologist",
        "specialty": "nephrology",
        "name": "Dr. Robert Martinez",
        "experience_years": 18,
        "credentials": "MD, FASN",
        "institution": "Academic Medical Center",
        "expertise": [
          "acute kidney injury",
          "drug-induced nephrotoxicity",
          "immune-mediated kidney disease",
          "glomerulonephritis",
          "acute tubular necrosis"
        ],
        "focus_areas": [
          "AKI differential diagnosis",
          "urinalysis interpretation",
          "kidney biopsy indications",
          "AKI staging and progression",
          "renal recovery patterns"
        ],
        "clinical_experience": "Kidney biopsy interpretation, drug-induced AKI, immune complex diseases",
        "reasoning_style": "systematic exclusion of causes, biopsy-correlation focused"
      },
      {
        "id": "pathologist",
        "specialty": "renal_pathology",
        "name": "Dr. Maria Rodriguez",
        "experience_years": 20,
        "credentials": "MD, PhD",
        "institution": "University Medical Center",
        "expertise": [
          "renal pathology",
          "acute tubulo-interstitial nephritis",
          "immune-mediated kidney pathology",
          "drug-induced nephritis",
          "electron microscopy"
        ],
        "focus_areas": [
          "histologic patterns of drug-induced AKI",
          "immune infiltrate characterization",
          "tubular injury patterns",
          "biopsy timing and yield",
          "pathologic-clinical correlation"
        ],
        "clinical_experience": "Interpreted >5000 kidney biopsies, specialized in drug-induced patterns",
        "reasoning_style": "morphology-based, pattern recognition, tissue-clinical correlation"
      },
      {
        "id": "pharmacist",
        "specialty": "clinical_pharmacy",
        "name": "Dr. James Wilson",
        "experience_years": 12,
        "credentials": "PharmD, BCOP, BCCCP",
        "institution": "Comprehensive Cancer Center",
        "expertise": [
          "oncology pharmacotherapy",
          "drug interactions",
          "pharmacokinetics/pharmacodynamics",
          "adverse drug reactions",
          "immunosuppressive medications"
        ],
        "focus_areas": [
          "drug-drug interactions affecting nephrotoxicity",
          "concomitant medication assessment",
          "dose modifications in renal impairment",
          "temporal drug exposure analysis",
          "alternative nephrotoxic causes"
        ],
        "clinical_experience": "Oncology pharmacy specialist, medication safety, drug interaction expertise",
        "reasoning_style": "pharmacologic mechanism-focused, drug timeline analysis"
      }
    ]
  }
}